![Infinity Pharmaceuticals Inc](/common/images/company/N_INFI.png)
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -0.1848 | -85.1612903226 | 0.217 | 0.25 | 0.0233 | 4083643 | 0.11702768 | CS |
156 | -3.0178 | -98.9442622951 | 3.05 | 3.89 | 0.0233 | 1969220 | 1.6177978 | CS |
260 | -1.6478 | -98.0833333333 | 1.68 | 5.98 | 0.0233 | 1485980 | 2.04442706 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.